Mission & Activity
Research Focus Areas
The final event “G4A Tokyo Dealmaker 2019 Signing Day” was held on 28 Oct at Tokyo. Bayer agreed on future collaboration with 6 innovative digital companies.
Bayer and RIKEN Innovation establish partnership in drug discovery.
“G4A Tokyo Dealmaker 2019” - The submission deadline is coming soon! (Close on July 19)
Bayer “G4A Tokyo Dealmaker 2019” Information sessions were held at Tokyo and Osaka. Looking forward to your application!
New business challenges were added to “G4A Tokyo Dealmaker 2019”. Information session will be held on 6 June at Osaka.
Bayer match-making/networking program“G4A Tokyo Dealmaker 2019”- Applications open now
“Bayer Pharmasimulation Workshop @Kyoto University” will be held on 7 Mar and 8 Mar.
Bayer and Kyoto University form research alliance to discover new treatment approaches against lung diseases
The final matching event “G4A Tokyo Dealmaker Day” was held on 26 Nov.
Bayer agreed on future potential collaboration with 12 innovative digital companies.
“G4A Tokyo Dealmaker 2018” - The submission deadline is coming soon! (Close on Sep 30)
Bayer “G4A Tokyo Dealmaker 2018” Information session -30 Aug at Tokyo-
Bayer match-making/networking program“G4A Tokyo Dealmaker 2018”- Applications open now
CoLaborator Kobe -Bayer’s startup incubator Website Opened
Bayer and PeptiDream to identify new active substance candidates through novel peptide-based screening technology
Symposiums: "Frontiers of Drug Discovery: Innovation Driven by Academic-Industry Collaboration" and "Frontiers of Drug Discovery: Precision Medicine and Academic-Industry Collaboration"
Bayer and Kyoto University Extend Collaborative Efforts to Identify Candidates for Research Projects
Bayer crowdsourcing program "Grants4Targets" accepted 6 applications from Japan in 2016
Thank you very much for joining the “Second digital health symposium presented by Kyoto University and Bayer Yakuhin, Ltd.: Early diagnosis and disease prevention.”
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
Second digital health symposium presented by Kyoto University and Bayer Yakuhin, Ltd.: Early diagnosis and disease prevention
Bayer HealthCare crowdsourcing program “Grants4Targets” accepts first application from Japan (Japanese only)
Survey on Science Innovation 2014
"Open Innovation Center Japan (ICJ)” Starts its Activities
Research Grant >>
Research Focus Areas >>
Mission & Activity >>
CoLaborator Kobe >>
Personal Information Protection Policy
Copyright ©Bayer Yakuhin, Ltd. All Rights Reserved.
Approval Number: PP-GEN-JP-0095-03-12